Your browser doesn't support javascript.
loading
Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.
Münk, Carsten; Jensen, Björn-Erik O; Zielonka, Jörg; Häussinger, Dieter; Kamp, Christel.
Afiliação
  • Münk C; Clinic for Gastroenterology, Hepatology and Infectiology, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany. carsten.muenk@med.uni-duesseldorf.de
Viruses ; 4(11): 3132-61, 2012 Nov 14.
Article em En | MEDLINE | ID: mdl-23202519
ABSTRACT
Human immunodeficiency virus-1 (HIV-1) dynamics reflect an intricate balance within the viruses’ host. The virus relies on host replication factors, but must escape or counter its host’s antiviral restriction factors. The interaction between the HIV-1 protein Vif and many cellular restriction factors from the APOBEC3 protein family is a prominent example of this evolutionary arms race. The viral infectivity factor (Vif) protein largely neutralizes APOBEC3 proteins, which can induce in vivo hypermutations in HIV-1 to the extent of lethal mutagenesis, and ensures the production of viable virus particles. HIV-1 also uses the APOBEC3-Vif interaction to modulate its own mutation rate in harsh or variable environments, and it is a model of adaptation in a coevolutionary setting. Both experimental evidence and the substantiation of the underlying dynamics through coevolutionary models are presented as complementary views of a coevolutionary arms race.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mutagênese / HIV-1 / Citosina Desaminase / Produtos do Gene vif do Vírus da Imunodeficiência Humana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Viruses Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mutagênese / HIV-1 / Citosina Desaminase / Produtos do Gene vif do Vírus da Imunodeficiência Humana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Viruses Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Alemanha